Researchers report the ability to improve safety and efficacy using a CRISPR-Cas9 variant known as miCas9.
Using a new variant to repair DNA will improve both safety and effectiveness of the much-touted CRISPR-Cas9 tool in genetic research, Michigan Medicine researchers say.
Those two key problems – safety and efficacy – are what continue to hold CRISPR-Cas9 gene targeting back from its full clinical potential, explains co-senior author Y. Eugene Chen, M.D., Ph.D., a professor of internal medicine, cardiac surgery, physiology, pharmacology and medicinal chemistry, from the Michigan Medicine Frankel Cardiovascular Center.
The new CRISPR-Cas9 variant improves efficiency when inserting a gene or DNA fragment to a precise location in the genome, known as knocking in. It also reduces the rate of unintended insertions or deletions, known as indels, of base pairs that often happen while gene editing.
“We name it meticulous integration Cas9, or miCas9, to reflect its extraordinary capacity to enable maximum integration, yet with minimal indels, as well as to recognize its development at the University of Michigan,” write senior authors Chen, Jifeng Zhang and Jie Xu for Nature’s “Behind the Paper” series. “It provides a ‘one small stone for three birds’ tool in gene editing.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Feed has no items.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- New gene therapy restores dystrophin protein in patients with Duchenne muscular dystrophyon May 2, 2021 at 10:43 pm
UT Southwestern scientists successfully employed a new type of gene therapy to treat mice with Duchenne muscular dystrophy (DMD), uniquely utilizing CRISPR-Cas9-based tools to restore a large section ...
- Harvard scientists create gene-editing tool that could rival CRISPRon May 1, 2021 at 4:33 pm
Harvard's Wyss Institute has created a new gene-editing tool that enable scientist to perform millions of genetic experiments simultaneously.
- Whole-genome sequencing reveals rare off-target mutations in CRISPR/Cas9-edited grapevineon May 1, 2021 at 12:57 am
To assess the off-target mutation rate in grapevine (Vitis vinifera), we performed whole-genome sequencing (WGS) of seven Cas9-edited grapevine plants in which one of two genes was targeted by ...
- Correcting mutations in muscle stem cells using new gene-editing technologyon April 30, 2021 at 7:00 pm
A new gene-editing technique can be used to correct mutations in muscle stem cells, paving the way for the first potential cell therapy for genetic muscle disorders.
- Move over CRISPR, the retrons are comingon April 30, 2021 at 7:31 am
While the CRISPR-Cas9 gene editing system has become the poster child for innovation in synthetic biology, it has some major limitations. CRISPR-Cas9 can be programmed to find and cut specific pieces ...